A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes
Eligible breast cancer patients with mastectomy and axillary dissection are randomized into
2 groups:radiotherapy of 50 Gy in 25 fractions within 5 weeks to ipsilateral chest wall and
supraclavicular nodal region,and no radiotherapy.
During and after radiotherapy, the patients are followed and the efficacy and toxicities of
radiotherapy are evaluated.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
overall survival
10 years
No
Ye-xiong Li, M.D.
Study Chair
Cancer Hospital, Chinese Academy of Medical Sciences
China: Ethics Committee
LC2008B06
NCT00805597
June 2008
Name | Location |
---|